Pharmaberater m/w/d Pulmologie at IQVIA

Nuremberg, Bavaria, Germany

IQVIA Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Experience as a Pharmaceutical Advisor, Pharmaceutical Representative, or Clinical Representative in various indications
  • Scientific education (ideally a university degree) or training as a Certified Pharmaceutical Representative (§75 AMG)
  • Strong communication skills and a willingness to work independently and results-oriented
  • Assertive personality and experienced networker
  • Desire to make a difference for patients

Responsibilities

  • Provide intensive support to selected physicians in the COPD/Asthma area
  • Promote the prescription of IQVIA’s products
  • Implement consulting strategies based on expertise
  • Discover innovative therapeutic concepts in challenging indications
  • Conduct regional and central training events in coordination with the Regional Manager and the regional team

Skills

Pharmaceutical Sales
Pulmonology
COPD
Asthma
Physician Engagement
Consulting Strategies
Sales Training
Networking
Communication

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI